Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects.
Condition: T2DM Interventions: Drug: Chiglitazar; Drug: Empagliflozin; Drug: Atorvastatin; Drug: Valsartan Sponsor: Chipscreen Biosciences, Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2023 Category: Research Source Type: clinical trials